Medical Bulletin 16/October/2023 Isra Zaman16 Oct 2023 3:01 PM ISTSARS-CoV-2 Variants of Concern in Children and Adolescents: Insights from a Comprehensive Study In the ongoing fight against the COVID-19 pandemic,...
Pfizer gets USFDA nod for Braftovi plus Mektovi for BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer Ruchika Sharma14 Oct 2023 10:30 AM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI (encorafenib) + MEKTOVI (binimetinib)...
Takeda to voluntary withdraw lung cancer therapy Exkivity Ruchika Sharma4 Oct 2023 4:30 PM ISTOsaka: Takeda has announced that, following discussions with the U.S. Food and Drug Administration (FDA), it will be working with the FDA...
Phase 3 Mariposa study evaluating Rybrevant plus Lazertinib meets primary endpoint in PFS in Non-Small Cell Lung Cancer: Janssen Ruchika Sharma2 Oct 2023 10:00 AM ISTRartan: The Janssen Pharmaceutical Companies of Johnson & Johnson has announced positive topline results from the Phase 3 MARIPOSA study...
Combination immunotherapy before surgery promising for patients with non-small-cell lung cancer Dr. Kamal Kant Kohli29 Sept 2023 8:00 PM ISTUSA: Findings from a novel multicenter phase 2 NeoCOAST platform trial revealed that patients with stage 1-3 non-small cell lung cancer (NSCLC) given...
Exhaled breath analysis promising for detection of malignant pleural mesothelioma Dr. Kamal Kant Kohli29 Sept 2023 10:45 AM ISTBelgium: A recent study has shown the potential of volatile organic compounds (VOCs) in exhaled breath as a non-invasive marker for malignant pleural...
Perioperative regimen of neoadjuvant Opdivo, chemotherapy improves event free survival in Resectable Non-Small Cell Lung Cancer: Bristol Myers Squibb Ruchika Sharma25 Sept 2023 1:30 PM ISTPrinceton: Bristol Myers Squibb has announced the Phase 3 CheckMate -77T trial has met its primary endpoint of improved event-free survival...
Setback: Merck-Eisai combination therapy fails in lung cancer studies Ruchika Sharma23 Sept 2023 2:21 PM ISTNew Jersy: Drugmakers Merck and Eisai said on Friday a combination of their cancer therapies did not prolong the lives of patients in two...
Merck gets positive EU CHMP opinion for Keytruda as adjuvant treatment for adults with Non-Small Cell Lung Cancer Ruchika Sharma18 Sept 2023 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency’s Committee for Medicinal...
AstraZeneca Enhertu recommended for nod in EU by CHMP for HER2-mutant advanced non-small cell lung cancer Ruchika Sharma16 Sept 2023 1:30 PM ISTCambridge: AstraZeneca and Daiichi Sankyo’s (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for...
Gilead Sciences Trodelvy, Keytruda combo study demonstrates promising clinical activity in first-line Metastatic Non-Small Cell Lung Cancer Ruchika Sharma12 Sept 2023 2:30 PM ISTFoster City: Gilead Sciences, Inc. has announced promising early data from the global, open-label, Phase 2 EVOKE-02 study evaluating Trodelvy...
AstraZeneca declares positive results from trial of Tagrisso plus chemotherapy to treat EGFR-mutated advanced lung cancer Ruchika Sharma12 Sept 2023 1:30 PM ISTCambridge: AstraZeneca has announced positive results from FLAURA2 phase III trial of Tagrisso (osimertinib) in combination with chemotherapy for...
